Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 6, 2007, Pages 2230-2235

  Stone, Kimberley Clawson ^a   Dagan, Ron ^b   Arguedas, Adriano ^c   Leibovitz, Eugene ^b   Wang, Elaine ^d   Echols, Roger M ^d   Janjic, Nebojsa ^a   Critchley, Ian A ^a  

^a Replidyne Inc   (United States)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Instituto de Atencion Pediatrica Costa Rica   (Costa Rica)

^d Replidyne Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; FROPENEM;

ACUTE OTITIS MEDIA; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; COSTA RICA; DIARRHEA; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG SAFETY; HAEMOPHILUS INFLUENZAE; HUMAN; ISRAEL; MICROORGANISM; MIDDLE EAR; MINIMUM INHIBITORY CONCENTRATION; MORAXELLA CATARRHALIS; NAUSEA; NONHUMAN; PRIORITY JOURNAL; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; VOMITING;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CHILD; COSTA RICA; EAR, MIDDLE; HAEMOPHILUS INFLUENZAE; HUMANS; ISRAEL; MICROBIAL SENSITIVITY TESTS; MORAXELLA (BRANHAMELLA) CATARRHALIS; OTITIS MEDIA WITH EFFUSION; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES;

EID: 34250191804     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00049-07     Document Type: Article

References (23)

1. Berman, S. 1995. Otitis media in children. N. Engl. J. Med. 332:1560-1565.
2. Brunton, S. 2006. Current face of acute otitis media: microbiology and prevalence resulting from widespread use of heptavalent pneumococcal conjugate vaccine. Clin. Ther. 28:118-123.
3. Casey, J. R., and M. E. Pichichero. 2004. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr. Infect. Dis. J. 23:824-828.
4. Clinical and Laboratory Standards Institute. 2006. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S16. Clinical and Laboratory Standards Institute, Wayne, PA.
5. Critchley, I. A., J. A. Karlowsky, D. C. Draghi, M. E. Jones, C. Thornsberry, K. Murfitt, and D. F. Sahm. 2002. Activities of faropenem, an oral β-lactam, against recent U.S. isolates of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis. Antimicrob. Agents Chemother. 46:550-555.
6. Dabernat, H., C. Delmas, M. Seguy, R. Pelissier, G. Faucon, S. Bennamani, and C. Pasquier. 2002. Diversity of β-lactam resistance-conferring amino acid substitutions in penicillin-binding protein 3 of Haemophilus influenzae. Antimicrob. Agents Chemother. 46:2208-2218.
7. Dagan, R. 1998. Can the choice of antibiotics for therapy of acute otitis media be logical? Eur. J. Clin. Microbiol. Infect. Dis. 17:1-5.
8. Dalhoff, A., and C. J. Thomson. 2003. The art of fusion: from penams and cephems to penems. Chemotherapy 49:105-120.
9. Felmingham, D., and J. Washington. 1999. Trends in the antimicrobial susceptibility of bacterial respiratory tract pathogens - findings of the Alexander Project 1992-1996. J. Chemother. 11(Suppl. 1):5-21.
10. Harada, Y., T. Matsumoto, Y. Tsuji, I. Gondou, N. Kobayashi, K. Hayashi, T. Uchida, Y. Uehara, T. Kido, and T. Fukuda. 1995. Pharmacokinetic and clinical studies on SY5555 dry syrup in children. Jpn. J. Antibiot. 48:261-270.
11. Jacobs, M. R. 2000. Increasing antibiotic resistance among otitis media pathogens and their susceptibility to oral agents based on pharmacodynamic parameters. Pediatr. Infect. Dis. J. 19:S47-S55.
12. Jacobs, M. R., R. Dagan, P. C. Appelbaum, and D. J. Burch. 1998. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob. Agents Chemother. 42:589-595.
13. Jenkins, S. G., D. J. Farrell, M. Patel, and B. S. Lavin. 2005. Trends in anti-bacterial resistance among Streptococcus pneumoniae isolated in the USA, 2000-2003: PROTEKT US years 1-3. J. Infect. 51:355-363.
14. Karlowsky, J. A., C. Thornsberry, I. A. Critchley, M. E. Jones, A. T. Evangelista, G. J. Noel, and D. F. Sahm. 2003. Susceptibilities to levofloxacin in Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis clinical isolates from children: results from 2000-2001 and 2001-2002 TRUST studies in the United States. Antimicrob. Agents Chemother. 47: 1790-1797.
15. Klein, J. O. 1994. Otitis media. Clin. Infect. Dis. 19:823-833.
16. Qin, L., H. Watanabe, N. Asoh, K. Watanabe, K. Oishi, T. Mizota, and T. Nagatake. 6 September 2006. Antimicrobial susceptibility and genetic characteristics of Haemophilus influenzae isolated from patients with respiratory tract infections between 1987 and 2000, including β-lactamase-negative ampicillin-resistant strains. Epidemiol. Infect. doi:10.1017/S0950268806007023.
17. Sakai, A., M. Hotomi, D. S. Billal, K. Yamauchi, J. Shimada, S. Tamura, K. Fujihara, and N. Yamanaka. 2005. Evaluation of mutations in penicillin binding protein-3 gene of non-typeable Haemophilus influenzae isolated from the nasopharynx of children with acute otitis media. Acta Otolaryngol. 125:180-183.
18. Sanbongi, Y., T. Suzuki, Y. Osaki, N. Senju, T. Ida, and K. Ubukata. 2006. Molecular evolution of β-lactam-resistant Haemophilus influenzae: 9-year surveillance of penicillin-binding protein 3 mutations in isolates from Japan. Antimicrob. Agents Chemother. 50:2487-2492.
19. Shimada, J., H. Takemura, K. Funahashi, and T. Kajiura. 2003. Surveillance of susceptibility of clinical isolates to various antibiotics including faropenem: antibacterial activity against aerobic bacteria isolated from common infections during 1998-2003. Jpn. J. Chemother. 51:680-692.
20. Siegert, R., O. Berg, P. Gehanno, A. Leiberman, J. L. Martinkenas, P. Nikolaidis, P. Arvis, M. Alefelder, and P. Reimnitz. 2003. Comparison of the efficacy and safety of faropenem daloxate and cefuroxime axetil for the treatment of acute bacterial maxillary sinusitis in adults. Eur. Arch. Otorhinolaryngol. 260:186-194.
21. Soley, C., A. Arguedas, W. Porras, S. Guevara, C. Loaiza, A. Perez, G. Rincon, M. Schultz, J. Arguedas, and R. Brilla. 2005. In vitro activities of levofloxacin and comparable agents against middle ear fluid, nasopharyngeal, and oropharyngeal pathogens obtained from Costa Rican children with recurrent otitis media or failing other antibiotic therapy. Antimicrob. Agents Chemother. 49:3056-3058.
22. Ubukata, K., Y. Shibasaki, K. Yamamoto, N. Chiba, K. Hasegawa, Y. Takeu chi, K. Sunakawa, M. Inoue, and M. Konno. 2001. Association of amino acid substitutions in penicillin-binding protein 3 with β-lactam resistance in β-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrob. Agents Chemother. 45:1693-1699.
23. Upchurch, J., M. Rosemore, R. Tosiello, S. Kowalsky, and R. Echols. 2006. Randomized double-blind study comparing 7- and 10-day regimens of faropenem medoxomil with a 10-day cefuroxime axetil regimen for treatment of acute bacterial sinusitis. Otolaryngol. Head Neck Surg. 135:511-551.